Graphical Abstract Highlights
A rapid accumulation of Treg cells relative to T effector (Teff) cells-in which more than 30% of the infiltrating lymphocytes are Treg cells-occurs in inflamed tissue during immune regulation (Tang et al., 2012) . By contrast, the small proportion of these cells in the peripheral blood (2%-5%) further emphasizes their remarkable migratory ability.
The bioenergetics of Teff and Treg cell function, expansion, and survival has been extensively studied. Teff and Treg cells require distinct metabolic programs to support their survival and differentiation: T helper (Th)1, Th2, and Th17 cells express high surface amounts of glucose transporter Glut1 and are highly glycolytic, whereas Treg cells express low amounts of Glut1 and have high lipid oxidation rates in vitro (Michalek et al., 2011) . The mammalian target of rapamycin (mTOR) plays a key role in cell fate decision by regulating T cell metabolic responses. T cell activation stimulates mTOR to increase glycolysis and diminish lipid oxidation (Wieman et al., 2007) . In contrast, blockade of glycolysis promotes generation of Treg cells, and this occurs via inhibition of mTOR-mediated induction of the transcription factor hypoxia-inducible factor (HIF1a) (Dang et al., 2011; Shi et al., 2011) . However, while Treg cells mainly rely upon an oxidative metabolism, some specific functions can be dependent on a selective switch to glycolysis. Their metabolism appears to oscillate from mTOR-dependent and -independent pathways in response to environmental cues (Procaccini et al., 2010) . Tolllike receptor (TLR) signals promote Treg cell proliferation via mTORC1 signaling, glycolysis, and Glut1 upregulation, but these signals also reduce their suppressive ability (Gerriets et al., 2016) .
Despite motility being likely the most energy-consuming cellular activity (Bernstein and Bamburg, 2003) , the metabolic demands for T cell migration have been only partly investigated. We have shown that Teff cell migration relies upon the glycolytic pathway (Haas et al., 2015) . However, the metabolic program(s) that fuel Treg cell migration remain unknown.
Integrins such as LFA-1 play a key role T cell trafficking; in addition, signals generated by the co-stimulatory or the co-inhibitory receptors CD28 and CTLA-4, respectively, actively participate in the regulation of T cell trafficking. In the lymph nodes, CD28 activation promotes memory T cell egression and migration to target tissue (Jain et al., 2013; Mirenda et al., 2007) , while CTLA-4 antagonizes CD28 pro-migratory signals (Mirenda et al., 2007) . Effector Treg cell migration is also regulated by CD28 signals (M€ uller et al., 2008) . Importantly, costimulatory receptors also regulate T cell metabolic reprogramming to enhanced glycolysis (Frauwirth et al., 2002; Parry et al., 2005) , suggesting that glycolysis and migration might be tightly linked in Treg cells.
By comparing LFA-1-and CD28-mediated pro-migratory signals as a working model, we have investigated the bioenergetics of migrating Treg cells in vitro and in vivo. We here define a specific pathway of metabolic reprogramming sustaining Treg cell migration both in mice and humans.
RESULTS

Engagement of the Glycolytic Pathway Is Required for Treg Cell Migration
Given that Treg cells display high lipid oxidation, we first tested the hypothesis that ex vivo expanded thymic Treg cell migration may require fatty acid oxidation (FAO) by exposing the cells to acetyl-CoA carboxylase (ACC) inhibitor Etomoxir (Figures S1B and S1C) . This pre-treatment did not affect Treg cell transendothelial migration (TEM) or chemotaxis in vitro ( Figures 1A, 1D , and 1E, respectively, and S1A-S1E) or migration to inflamed peritoneum in vivo (Figures 1F and 1G) .
We subsequently explored the possibility that, like conventional T cells (Tconv), Treg cells utilize glycolysis for migration, by inhibiting this pathway with the glucose analog 2-deoxyglucose (2-DG). Treg cells exposed to 2-DG migrated inefficiently both in vitro ( Figures 1B, 1D , 1E, S1D, and S1E) and in vivo (Figures 1H and 1I) . In addition to extensive washing after exposure to the drugs, the inhibition of Treg cell chemotaxis excludes indirect effects of the drugs on the endothelium in these conditions. In contrast, activation of glycolysis using metformin, which stimulates glycolysis via AMP kinase, increased Treg cell motility S1D , and S1E) and trafficking (Figures 1J and 1K) . None of the drugs affected expression of migration-relevant receptors or viability at the doses used (Figures S1F and S1G) . To confirm that the effect of each of these compounds is retained once in vitro treated T cells are injected into recipient mice, Treg cells were exposed to the various drugs for 4 hr, extensively washed, and incubated in culture medium alone for a further 16 hr. The effects on drug-treated cell motility were still apparent after the prolonged incubation without the compounds ( Figures  S1I-S1N) .
To confirm the induction of the glycolytic pathway by promigratory stimuli, we subsequently tested the effect of engagement of the adhesion molecule integrin LFA-1, a key mediator of T cell migration, on aerobic glycolysis in Treg cells. Immobilized or antibody-ligated recombinant mouse ICAM-1 (rICAM-1), a ligand of LFA-1, was used for this purpose.
First we estimated LFA-1-induced glucose uptake using the glucose analog 6-[N-(7-nitrobemz-2-oxa-1,3-diazol-4-yl) amino]-2-deoxyglucose (6-NBDG), which cannot be phosphorylated by hexokinases and accumulates in the cytoplasm in its fluorescent form. Treg cells were stimulated with plastic-bound rICAM-1 or human IgG Fc fragments (control) and 6-NBDG uptake was measured 30 min later by flow cytometry. As shown in Figures 1L and 1M , LFA-1 stimulation significantly increased 6-NBDG uptake.
Second, we measured the effects of LFA-1 engagement or exposure to the chemokine CCL22 (CCR4 ligand) on the extracellular acidification rate (ECAR), which quantifies proton production as a surrogate for lactate production and thus reflects overall glycolytic flux. ECAR increase upon glucose supply was significantly enhanced following LFA-1 or CCR4 ( Figures 1N  and 1O ) stimulation. Meanwhile, the oxygen consumption rate (OCR), a measure of mitochondrial respiration, was not affected ( Figures S1N and S1O ).
CD28 and CTLA-4 Regulate Treg Cell Migration through Modulation of the Glycolytic Pathway As triggering of LFA-1 by endothelial ICAM-1 is a frequent event during recirculation-hence difficult to manipulate-to address the metabolic requirement of Treg cell trafficking in vivo we subsequently focused on the effects CD28 and CTLA-4 ( Figure S2A ) costimulatory and coinhibitory signals, which can be delivered ex vivo with well-characterized reagents ( Figure S2B ).
First, we confirmed that antibody activation of CD28 enhances ex vivo expanded Treg cell TEM ( Figure S2C ) and chemotaxis ( Figures S2D and S2E ) in vitro and migration in vivo ( Figure S2F ), without affecting expression of relevant receptors (Figures S2G and S2H) . Also, we observed that while CTLA-4 triggering alone did not affect cell migration, co-ligation with CD28 abrogated CD28-induced migration ( Figures S2C  and S2D ). (legend continued on next page) Second, we measured the impact of CD28 and CTLA-4 signals on the glycolytic pathway in Treg cells. CD28 triggering significantly increased 6-NBDG uptake (Figures 2A and 2B ) and glycolytic flux ( Figure 2C ) compared to treatment with an isotype control and secondary antibodies. In contrast, CTLA-4 stimulation did not affect either glucose uptake or ECAR on its own but when co-ligated, CTLA-4 signals prevented CD28-induced glucose uptake and ECAR increase. The oxygen consumption rate (OCR) was not affected by triggering of either costimulatory receptor ( Figures S2I and S2J) .
We further explored the link between costimulatory signals and metabolic regulation of motility by analyzing the metabolic activity and migration of Ctla4 À/À Treg cells. In these experiments we used as stimulator recombinant (r)CD80, a ligand shared by CD28 and CTLA-4. Compared to WT Treg cells, Ctla4 À/À cells displayed a prolonged increase of ECAR in response to glucose ( Figure 2D )-even taking into account a higher acidification baseline. As expected, the ECAR of WT Treg cells activated with recombinant CD80 remained unchanged, due to simultaneous CD28 and CTLA-4 engagement ( Figure 2E ), while Ctla4 À/À cells further increased their glycolytic response to glucose addition ( Figure 2F ). Despite the fact that Ctla4 À/À cell OCR was spontaneously higher than that of their WT counterparts, it was not affected by either CD28 or CTLA-4 signals ( Figure S2K) . In parallel, we tested TEM by rCD80-stimulated Ctla4 To investigate whether control of Treg cell migration by CD28 and CTLA-4 occurs via modulation of glycolysis, we analyzed the effect of CD28 and/or CTLA-4 stimulation during TEM in glucose-depleted medium. As shown in Figure 2H , glucose depletion prevented the increase in motility induced by CD28 signals. The results were not influenced by cell distress associated with glucose deprivation as baseline migration remained similar in both glucose-sufficient and -deficient conditions.
In vivo, the CD28-glycolysis-migration axis was analyzed by monitoring 6-NBDG uptake by CD28-stimulated migrating Treg cells. To this aim, we used a tissue infiltration model in which the ability of Treg cells injected in the peritoneal cavity to infiltrate the peritoneal membrane is quantified (Mirenda et al., 2007) . This model was chosen because 6-NBDG fluorescence is rapidly lost with time, making it technically impossible to track T cells transferred intravenously long-term. Treg cells were labeled with PKH26 (red fluorescence) and then underwent CD28 ligation with or without CTLA-4 triggering, or received isotype-matched and secondary antibodies as a control prior to i.p. injection in syngeneic mice treated with IFN-g 48 hr earlier. 6-NBDG (green fluorescence) was injected i.p. immediately after the cells, thus allowing parallel evaluation of tissue infiltration and glucose uptake by labeled Treg cell in vivo. As shown in Figures 2I-2K , CD28 activation substantially increased the number of cells infiltrating the peritoneum and displaying 6-NBDG uptake (yellow fluorescence), indicating that Treg cell migration directly correlates with glucose uptake in vivo. Both these effects were prevented by CTLA-4 co-ligation.
Enhancement of Glycolysis and Migration Requires PI3K-Akt Activation but Is Independent of mTORC1 CD28 stimulation induces glucose uptake and glycolysis via activation of the PI3K-Akt signaling pathway (Frauwirth et al., 2002; Jacobs et al., 2008) . PI3K activation by CD28 is instrumental for the transduction of pro-migratory signals, without affecting expression of migratory receptors, in conventional T (Tconv) cells (Jarmin et al., 2008) , and inefficient migration of T cells to the inflammatory site is a feature of Cd80
Cd86
À/À mice (Chang et al., 1999) . To investigate the role of CD28-induced activation of the PI3K pathway on Treg cell metabolism and migration, we isolated Treg cells from Cd28 Y170F genetically targeted mice, which carry a mutation in the cytoplasmic tail of CD28 that selectively prevents recruitment of PI3K (Okkenhaug et al., 2001) . Cd28 Y170F Treg cells display normal development (Tai et al., 2005) and expression of migration-relevant and other receptors ( Figure S3A ). First, we compared the mobilization and recirculation of WT and Cd28 Y170F Treg cells following i.p. injection of Zymosan.
Activation of innate but not adaptive immunity by this method has been shown to induce accumulation of Treg cells in the peritoneal cavity with a peak 72 hr after injection (Newson et al., 2014) . As shown in Figures 3A and (K), respectively (n = 4, N = 2). *p < 0.05; **p < 0.01; ***p < 0.005. Please see also Figure S2 .
the ECAR increase in CD28-stimulated Cd28 Y170F cells was significantly dampened (Figure 3E ), suggesting that PI3K recruitment by CD28 signals is required to efficiently induce glycolysis.
We then analyzed the migratory response to CD28 triggering by Treg cells isolated and expanded from both WT and Cd28 Y170F mice. As shown in Figures 3F-3J , CD28 stimulation failed to enhance migration of Cd28 Y170F Treg cells in vitro (Figure 3F) and in vivo ( Figures 3G-3J ), confirming the pivotal role of CD28-mediated recruitment of PI3K in enhancing Treg cell migration. In most T lymphocytes, mTOR kinase couples upstream PI3K and Akt to glucose uptake and glycolysis (Chi, 2012; Powell and Delgoffe, 2010) . In Treg cells, CD28 signals induced phosphorylation of the mTORC1 target ribosomal protein S6 ( Figure S3C ), an event that was prevented by CTLA-4 co-ligation. Rapamicyn treatment prevented Treg cells entering the cell cycle-as measured by the expression of the proliferating cell nuclear antigen (PCNA)-in response to immature cognate DCs and rIL-2 ( Figure S3D ), and CD28-induced phosphorylation of ribosomal protein S6 ( Figure S3E ). However, rapamycin did not affect CD28-induced migration in vitro (Figures S3F and S3G) or in vivo ( Figures S3H-S3K ), suggesting that CD28 promotes Treg cell migration via mediators downstream of PI3K other than mTORC1.
Pro-migratory Stimuli Induce Metabolic Reprogramming
We have previously shown that in Tconv cells, activation of glycolysis during migration occurs via transcriptional and posttranscriptional regulation of the enzyme Hexokinase (HK)I (Haas et al., 2015) . We therefore analyzed the expression of a number of glycolytic enzymes by expanded Treg cells 4 hr after CD28 and CTLA-4 stimulation. CD28 stimulation led to a modest increase in HKI, Enolase, and Aldolase expression by Treg cells (Figures 4A and 4B ). The most substantial increase was observed in the expression of the HK isoenzyme glucokinase (HKIV or GCK), a rate-limiting enzyme key to hepatocyte and pancreatic beta cell function, whose expression by T cells has not been previously reported. Concomitant CTLA-4 triggering inhibited CD28-induced enzyme expression.
We extended our analysis also to HKII and observed that, like that of GCK, a substantially enhanced expression of this enzyme occurred as early as 5 min after stimulation not only by CD28 signals, but also following LFA-1 triggering by recombinant ICAM-1 ( Figures 4C, S4A , and S4B), suggesting that both stimuli enhance enzyme expression also by post-transcriptional mechanisms.
We then measured transcription of the GCK, HKI, and HKII genes, which was indeed increased by LFA-1 or CD28 stimulation ( Figures 4D, S4C , and S4D, respectively). As expected, enzyme induction by CD28 was prevented by CTLA-4 triggering. In this set of experiments, transcription of the GCK regulatory protein (GCKR) gene ( Figure 4E ), a post-transcriptional regulator which blocks free cytoplasmic GCK (Farrelly et al., 1999) , was also analyzed. Confocal analysis of expression and co-localization of GCK and GCKR following CD28 and LFA-1 activation confirmed that both CD28 and LFA1 stimuli decrease GCKR expression, concomitant to a substantial increase of GCK availability (Figures 4F and 4G) .
To address the relative contribution of HKII and GCK activity to their motility, Treg cells were treated with either the GCK activator AZD1656 (Waring et al., 2012) or with the HKII-selective inhibitor Clotrimazole (CLT), which inhibits the glycolytic flux and respiration in CD3 plus CD28-stimulated Tconv cells (Figures S4E and S4F; van der Windt et al., 2013) . GCK activation significantly enhanced Treg cell migration to the inflamed tissue (Figure 4H) but did not affect division ( Figure 4I ). Conversely, CLT was effective at inhibiting PCNA upregulation by Treg cells ( Figure 4J ) in response to allogeneic DCs but did not affect rICAM-1-mediated induction of glycolysis ( Figure 4K ) or migration to inflamed peritoneum in vivo ( Figure 4L ), implying that HKII is redundant for Treg cell migration.
mTORC2-Dependent Induction of GCK Expression Is Required for Treg Cell Migration
The above observations implicate GCK as a key enzyme induced by both CD28-and LFA-1-mediated signals in migrating Treg cells. GCK expression in the liver is regulated by the relatively rapamycin-insensitive mTORC2 (Hagiwara et al., 2012) .
Based on this evidence and the observation that CD28-induced Treg cell trafficking is PI3K dependent but rapamycin insensitive (Figures 3 and S3) , we examined the contribution of mTORC2 signaling to Treg cell metabolism and migration. First, we confirmed that CD28 triggering led to mTORC2-dependent AKT phosphorylation at the serine residue 473 (Figure 5A ). Subsequently, expression of Rictor, an obligatory component of mTORC2, was prevented in expanded Treg cells by lentivirus-delivered, specific shRNAs ( Figures S5A and S5B ). For comparison we also silenced GCK expression. As a control, cells were transduced with an empty vector (PLKO.1). Gene silencing did not affect cell survival ( Figures S5C and S5D ). Rictor-depleted Treg cells became unable to upregulate GCK protein expression following CD28 and LFA-1 stimulation (legend continued on next page) ( Figure 5B), suggesting that this event was mTORC2 dependent. Confocal analysis of Rictor-deficient cells confirmed their failure to upregulate GCK expression in response to the promigratory signals compared to mock-transduced cells ( Figures  5C and 5D ). Furthermore, Treg cells lacking mTORC2 activity did not downregulate GCKR expression ( Figure 5E ). The ability of Rictor-and GCK-shRNA silenced Treg cells to enhance the glycolytic flux upon CD28 or LFA-1 stimulation was also significantly impaired compared to mock-transduced cells (Figure 5F) . A glycolysis stress test showed that, although they were unable to increase the glycolytic flux in response to CD28 and LFA-1 signals, both Rictor-and GCK-deficient Treg cells maintained a basal and maximal glycolytic response ( Figures 5G and 5H ), while their glycolytic reserve was significantly impaired ( Figure 5I ). Despite these metabolic alterations, the suppressive and proliferative capacity of Rictor-and GCK-deficient Treg cells were similar to those of their mock-transduced counterpart ( Figures S6A-S6C ), indicating that this pathway was not required for these functions.
To assess whether the metabolic impairment resulted in alteration of migratory responses, differentially labeled cells transduced with Rictor-or GCK-specific or control shRNAs underwent CD28 or IsC antibody ligation prior to co-injection in syngeneic recipients, which had received a i.p. injection of IFN-g 48 hr earlier. Their migration to the peritoneal cavity, spleen, and LN was compared 16 hr later. Both Rictor-and GCK-depleted Treg cell migration to the inflammatory site was severely impaired compared to that by mock-transduced cells and was not enhanced by CD28 activation (Figures 6A and  6B ). In addition, although similar numbers of cells were injected, significantly lower numbers of GCK-deficient Treg cells were retrieved in the spleen-where early migration does not require active mechanisms-compared with Rictor-deficient or mocktransduced cells ( Figures 6C and 6D ). We hypothesized that the severe impairment of GCK-deficient Treg cell cytoskeleton might render them unable to squeeze through the pulmonary capillaries and leave the lungs following injection in the venous blood. Indeed, the ratio of GCK-deficient cells retrieved in the lung and the spleen was significantly increased compared to that of control cells independently of CD28 activation ( Figure 6E ). In addition, although inefficiently compared to mock-transduced cells, shGCK Treg cells were still capable of migrating through pores with a 5 mm diameter in chemotaxis assays, but failed to migrate through 3 mm pores ( Figures 6F and 6G) , suggesting a severe impairment of cytoskeletal function as a consequence of loss of GCK activity.
In this context, we observed that pro-migratory activity of CD28 signals was accompanied by intense actin remodeling, which was prevented by CTLA-4 signals (Figures S6D and S6E) . Glycolytic enzymes including GCK interact with actin (Clarke and Masters, 1975; Murata et al., 1997) to act as a glycolytic ATP feeder for the ATP-hydrolyzing sodium pump (Na,K-ATPase), thus generating energy required for cytoskeletal rearrangements (Jung et al., 2002) . We therefore assessed GCK and Na,K-ATPase localization on the actin cytoskeleton in CD28-and LFA-1-stimulated Treg cells. First, we observed that GCK became associated with actin following CD28 stimulation ( Figure S6F ). Further, unstimulated cells displayed reduced F-actin and GCK expression, which appeared associated with the cytoskeleton (Figures S6G-S6I) . Similarly, ATPase expression was low and only partially co-localized with GCK ( Figures S6G, S6H , and S6J). Stimulation of CD28 or ICAM led to intense F-actin formation and upregulation of associated GCK and increased expression of the Na,K-ATPase, which also associated with GCK ( Figures  S6G-S6I ). As expected, since shRictor-silenced Treg cells produce less GCK, the amount of co-localization with F-actin was also lower.
To further confirm the selective impact of Rictor and GCK deficiency on Treg cell motility, we finally compared the ability of adoptively transferred (10 7 /mouse) control, Rictor-deficient, or GCK-deficient cells to delay rejection of fully allogeneic skin grafts. As expected, Rictor-and GCK-depleted Treg cells failed to prolong graft survival ( Figure 6H ) as they did not localize in the graft ( Figures 6I and 6J ) compared to mock-transduced cells. In line with previous results, fewer GCK-deficient cells were found also in the spleen.
Human Treg Cells from Homozygous Carriers of a Lossof-Function Polymorphism in the GCKR Gene Display Enhanced Motility
To test the physiological relevance of this pathway in the human system, we analyzed the number and functional behavior of circulating Treg cells (defined as CD25 hi CD127 lo ) from carriers of a loss-of-function polymorphism in the GCKR gene (C to T, P446L). P446L-GCKR has reduced inhibitory activity toward GCK and has been associated with decreased fasting plasma glucose and enhanced triglyceride synthesis (these parameters measured in our study population are shown in Figures S7A and S7B) via increased GCK activity in the liver of homozygous carriers (Beer et al., 2009) 
DISCUSSION
In this study we have investigated the metabolic pathways that sustain migration of thymic Treg cells and how these pathways become engaged by pro-migratory signals.
Our data indicate that migratory stimuli induce metabolic reprogramming of Treg cells toward aerobic glycolysis. However, while induction of the glycolytic pathway in dividing Treg lymphocytes relies upon mTORC1 activity (Gerriets et al., 2016; Procaccini et al., 2010) , activation of glucose metabolism induced by pro-migratory stimuli occurs via mTORC2.
The molecular mechanism for the selective engagement of mTORC2 for the induction of motility-associated glycolysis in Treg cells remains unclear. Physiologically, Treg cells display high activity of rapamycin-sensitive mTOR phosphorylation, which is transiently inhibited by environmental stimuli to allow their proliferation in vivo (Procaccini et al., 2010) . A simplistic explanation is that constitutively high mTORC1 activation might limit its availability for additional signals. Thus, glycolysis-activating stimuli in non-proliferating Treg cells may be redirected to the mTORC2 pathway.
Immunity 47, 875-889, November 21, 2017 885 Consistent with this hypothesis, mTORC2 regulates the glycolytic flux by fully activating AKT and controlling c-Myc expression which in turn regulate the transcription of genes that control glucose transport and glycolysis, including GLUT1 and HKII (Masui et al., 2014) . Finally, mTORC2 is known to mediate cytoskeleton reorganization (Cybulski and Hall, 2009 ) and substantial evidence suggests that its activation requires PI3K activity (Boulbes et al., 2010; Gan et al., 2011) , but its ability to promote cell migration via modulation of metabolic pathways has not previously been described.
The dichotomy between regulation of glycolysis during Treg cell proliferation and migration is also reflected in the enzymatic machinery engaged for these cellular responses. Metabolic reprogramming following antigen activation of conventional T cell involves a substantial increase of hexokinase activity, which is dependent on a transcriptional switch in HK isozyme expression from HKI to HKII, which has higher affinity for glucose (Bosca et al., 1988; Marjanovic et al., 1990; Wang et al., 2011) . In addition-and as a likely consequence of mTORC2 activation-pro-migratory signals substantially enhance GCK expression. In line with the non-redundant role of mTORC2 in the metabolic regulation of motility, GKC has been shown to be one of the main targets downstream of mTORC2-mediated signaling in the liver (Hagiwara et al., 2012) .
We have also provided evidence that this pathway might be operational in the human immune system. The number of circulating Treg cells was decreased in carriers of a GCKR loss-of-function variant and mutant Treg cells display enhanced motility, suggesting increased localization in tissues. Importantly, migration of Tconv cells is not affected by loss of GCKR inhibition and increased GCK activity. The impact of enhanced Treg cell trafficking on immune responses in these individuals will require further investigation.
The physiological significance of preferential utilization of GCK by migrating Treg cells remains to be defined by the use of mice with T cell-specific GCK deficiency. Unlike other hexokinases, GCK has a much lower affinity for glucose, which is within the physiological plasma glucose range (S0.5 z7 mM) and is less susceptible to inhibition by the glycolysis metabolite glucose 6-phosphate (Lenzen, 2014) . The use of GCK by Treg cells might explain the previous report of a delayed polarization rate of Treg cells, compared to Tconv cells, in response to CD28 stimulation (M€ uller et al., 2008) . CD28-stimulated Treg cells undergo early and late waves of migration, which might reflect the posttranscriptional and transcriptional increase in GCK expression, which we observed. GCK-which is not inhibited by glycolysis metabolites-might also maintain the glycolytic flux and survival in chronic inflammatory sites rich of inhibitory glycolysis metabolites, giving Treg cells an advantage over Tconv cells. In such environments, Tconv cells tend to become hyporesponsive and lose their function as a consequence, for example, of exposure to lactate (Haas et al., 2015) . Alternatively, or in addition, dependency on low-affinity GCK might promote retention of Treg cells in glucose-depleted tissues such as tumors.
During immune responses, the ability of CD28 and CTLA-4 to function as a metabolic switch might at least in part explain their opposing effects on T cell division and function. For example, transient CTLA-4 expression following activation might serve to shut down glycolysis, thus supporting reprogramming of longlived memory CD8 + T cells to FAO (O'Sullivan et al., 2014), thus promoting the contraction phase of T cell responses and maintaining homeostasis by favoring the induction of anergy (Zheng et al., 2009) . While the functional effects of CTLA-4 in the regulation of effector immunity are well established, the contribution of CTLA-4 to Treg cell function is not completely understood. CTLA-4-deficient mice display normal numbers of Treg lymphocytes, which however appear to be defective in their suppressive function in vivo (Wing et al., 2008) but not in vitro (Tang et al., 2004) . Our observations suggest that, by antagonizing CD28-induced migratory signals, CTLA-4 might be required for tissue retention rather than for Treg cell suppressive activity.
Impaired migration of Cd28 Y170F Treg cells in response to activation of innate immunity also indicates that CD28 signals instruct their mobilization and redistribution from lymphoid tissue -where CD28 engagement is likely to take place during interaction with activated DCs -to the blood stream. CD28-induced pro-migratory signals might dominate in the absence of cognate interactions thus supporting Treg cell recirculation. In contrast, transient upregulation of CTLA-4 by antigen-activation may reduce their motility leading to retention within tissues. In summary, this study defines a pathway for the metabolic regulation of motility and migration induced in Treg cells by pro-migratory stimuli. The apparent selectivity of this pathway in the regulation of motility of both murine and human Treg cells suggest that it might be possible to selectively manipulate trafficking of distinct lymphocyte subsets by targeting different glycolytic enzymes. Further, as the signaling mediators involved in the metabolic reprogramming of proliferating Treg cells are distinct from those regulating motility, selective targeting of these enzymes might allow the modulation of distinct functions in therapeutic settings.
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Isolation of microvascular endothelial cells
Murine lung microvascular endothelial cells were isolated as previously described (Marelli-Berg et al., 2000) . Mouse lungs were diced into 2-3mm 3 blocks, washed in phosphate buffered saline (PBS; Sigma-Aldrich, Cat# D8537) and digested in a solution containing 0.5mg/ml Type IV Collagenase (Sigma, Cat# C5138) for 30 minutes in a humidified incubator maintained at 37 C. A 70mm cell strainer (Fisher scientific, Cat# 22363548) was then used to remove undigested tissue while the digested tissue was collected and centrifuged at low rpm (< 250 g). The supernatant was aspirated and further digested in trypsin/ (EDTA) (GIBCO, Cat# E7889) at 37 C for 5 minutes to create a uniform cell suspension. The cell suspension was then washed with PBS at 300 g and resuspended in DMEM (GIBCO, Cat# 11966-025) containing 10% FBS (Seralab, Cat# A210009). The cells were then seeded in 2% gelatinated (Sigma-Aldrich, Cat# 1393) 25 cm 2 culture flasks (Helena biosciences, Cat# 90026) for 24 hours. After 24 hours, non-adherent cells were removed by washing with warm PBS and complete EC medium (mentioned below) was added to the culture. Isolation of bone marrow-derived Dendritic Cells (BMDCs) Bone marrow(BM)-derived DCs were obtained from WT BALB/c (H2-d) mice. Femurs and tibias from 7-to-10-week-old female mice were removed and BM cells were flushed out with PBS using a 27-gauge needle (Becton Dickinson, Cat# 302200). Red blood cells were lysed from the cell suspension with lysis buffer (Sigma-Aldrich, Cat# R7757). BM cells (5x10 6 ) were seeded per well in a 6 well plate (Helena bioscience, Cat# 92006) in DC medium as described below.
Culture of Dendritic cells
Bone marrow-derived dendritic cells were cultured in RPMI 1640 medium (GIBCO, Cat# 21875-034) supplemented with 10% FCS, 2mM glutamine, 50 IU/mL penicillin, 50 mg/mL streptomycin, 50 mM 2-ME and 2% murine granulocyte-macrophage colony stimulating factor (GM-CSF) obtained from the supernatant of the GMCSF hybridoma (gift from Dr. Jian-Guo Chai, Imperial College, London, UK). Cells were cultured at 37 C in the presence of 5% CO 2 . On days 3 and 5, fresh culture medium was added to the plates. For Treg-DC cell co-cultures, immature BMDCs were collected and used on day 6 of culture. For functional assays, immature DCs were matured overnight with 100ng/ml lipopolysaccharide (LPS) (Invivogen, Cat# tlrl-3pelps) and were used between day 7-10 postisolation. (Fu et al., 2014) . The co-cultures were maintained in complete T cell medium supplemented with 10U/ml IL-2. Cells were harvested and seeded at an optimal density of 1. Antibody-mediated T cell activation Activated T cells were obtained by polyclonal stimulation of LN cells with plate-bound anti-CD3 (1 mg/ml, eBiosciences, Cat# 16-0032-85) and plate-bound anti-CD28 (5 mg/ml, eBiosciences, Cat# 16-0281-86) in complete T cell medium supplemented with 20 U/ml recombinant IL-2 (Roche, West Sussex, UK) for 7 days at 37 C. Antibody coating of tissue culture plates was performed by incubating antibodies in 200 mL of Tris buffer (pH 8.5) at 37 C for 1 hour.
Culture of H2-d allospecific Treg cells
METHOD DETAILS
Lymphocyte trans-endothelial migration and chemotaxis assays Primary microvascular ECs treated with IFN-g for 48-72 h were seeded (3x10 4 ) and cultured on 2% gelatin-coated Transwell inserts (diameter, 6.5 mm) containing 3-mm pore size (Costar, Cat# CLS3472-48EA) polycarbonate membranes in EC medium for 16 h to from a monolayer. T cells (5x10 5 ) resuspended in migration medium (RPMI 1640 supplemented with 2% fetal bovine serum) were added to each insert and left to migrate through the monolayer; the well volume was also replaced with fresh migration media. The number of migrated T cells was determined by a hemocytometer counting of the cells present in the well media at different time points over a 24-h period. To measure chemotaxis, T cells were seeded onto Transwell bare-filter tissue culture well inserts (diameter, 6.5 mm) with 5-or 3-mm pore size (Costar, Cat# CLS3421-48EA) polycarbonate membranes and chemokine-containing migration medium was placed in the bottom of the well. The number of migrated cells was determined by a hemocytometer.
Assessment of Treg cell apoptosis
Apoptosis of Treg cells treated with increasing doses of TNFa (5 and 50 ng/ml, PeproTech,INC, Cat# 315-01A) or heat was measured using Annexin V-FITC Apoptosis Detection Kit (Abcam, Cat#ab14085). Cells were subsequently analyzed using flow cytometry.
Induction of CD28, CTLA-4 and LFA-1 signaling Induction of CD28 and CTLA-4 signaling by antibody stimulation was performed as previously described (Schneider et al., 2005; Wells et al., 2001 ). To induce co-stimulatory signals via CD28 and CTLA-4 co-receptors for functional assay, cells were incubated with antibodies targeting the functional domains of the co-receptors. To induce CD28 signaling, T cells were treated with a mixture of hamster anti-mouse CD28 (5 mg/5x10 6 cells) (clone: 37.52, Bio-Rad, Cat# MCA1363) and goat anti-hamster immunoglobulin (Ig) (2.5 mg/5x10 6 cells) (Bio-Rad, Cat# STAR104) for different time points as described in each figure separately. Similarly, CTLA-4 signaling was achieved by incubating T cells with a mixture of hamster anti-mouse CTLA-4 (5 mg/5x10 6 cells) (clone: UC10-4F10-11, Becton Dickinson, Cat# 553718), and goat anti-hamster immunoglobulin (Ig) (2.5 mg/5x10 6 cells) (Bio-Rad, Cat# STAR104). A hamster IgG isotype control was used to observe any non-specific effects of the antibody stimulation (Bio-Rad, Cat# MCA2356). To induce LFA-1 signaling, cells were incubated with 2 mg/5x10 6 cells recombinant mouse ICAM-1-human IgG Fc chimeras (2 mg/ml, R&D Systems, Cat# 796-IC-050) or human IgG-Fc fragments (R&D Systems, Cat# 110-HG) as a control -either plastic-bound or ligated with a mouse anti-human IgG (1 mg/ml, MK1A6, Bio-Rad Cat# MCA647G) -for different time points as described in each figure separately. T cells were washed in PBS prior to use in the experiments.
Fluorescent labeling of viable T cells
For labeling T cells with fluorescent probes, T cells were washed with PBS, counted and resuspended in PBS at a final concentration of 10 7 /ml. If necessary, dead cells were removed using density gradient centrifugation with Ficoll-Paque prior to re-suspension.
Labeling of T cells with PKH26 (Sigma-Aldrich, Cat# PKH26GL-1KT), a cell linker dye for cell membranes was performed using manufacturer instructions. PKH26 was added at a final concentration of 5mM, and the cells were incubated at room temperature for 5 minutes. The reaction was inactivated by adding an equal volume of FBS to the cell suspension and the cells were washed in PBS containing 10% FBS for 10 minutes. Labeling of T cells with succinimidyl ester dyes CFSE (Invitrogen, Cat# C1157) or DDAO-SE (Invitrogen, Cat# C34553) was performed by incubating the T cells in PBS containing final concentration of 3.3 mM CFSE or 1.3 mM DDAO-SE for 10-15 minutes at room temperature. The reaction was terminated by adding equal volume FBS and the cells were then washed with PBS containing 10% FBS for 10 minutes.
T cell recruitment in the peritoneum
To observe in vivo recruitment of T cells we used a previously described model (Mirenda et al., 2007) . Either PKH26 or CFSE or DDAO-SE-labeled T cells (10 7 ) were injected intravenously (i.v.) into mice that hd received IFN-g (600U) via intraperitoneal injection (i.p.) 48 to 72 hours earlier. Labeled T cells recovered via peritoneal lavage were analyzed 16 hours later using flow cytometry. In addition, localization of Treg cells to the spleen, where entry occurs in a passive manner, was analyzed to ensure that similar numbers/proportion of labeled cells were injected or co-injected in all recipients (internal control).
Zymosan-induced peritonitis
On day 0, mice were given intraperitoneal injections of Zymosan (1 mg/mouse, Cat# 4250 SIGMA) in sterile saline solution to induce peritonitis. Mice were sacrificed 72 hours post-injection and tissue samples obtained for flow cytometry analysis.
Widefield deconvolution fluorescence microscopy Tissues samples were excised, embedded in Optimal Cutting Temperature compound (OCT; Thermo Fisher Scientific, Cat# 12678646), snap-frozen and stored until analysis. Frozen tissue sections were laid onto Polysine coated microscope slides (VWR International, Cat# 47100), air-dried and then fixed with ice cold acetone (Sigma, Cat# 534064) for 10 min. Tissue sections were washed in PBS, blocked with serum for 3 hours and stained using mentioned primary antibodies at 4 C for 24 h. Excess antibody was washed away with PBS and tissues were stained with indicated secondary antibodies along with DAPI (4',6-diamidino-2-phenylindole) (Invitrogen/LifeTechnologies, Cat# D1306) for 30 min at room temperature. Slides were washed, mounted in ProLong Gold Antifade Reagent (Invitrogen/Life Technologies, Cat# P36930) and visualized using a Zeiss Z1 fluorescence microscope (Carl Zeiss, UK) equipped with an AxioCam MRm Cooled monochrome digital camera and an Apotome 2 Imaging unit. Images were acquired using a Plan Apochromat 20x/0.8 NA objective and Axiovision software version 4.8 (Carl Zeiss, UK). For staining, Treg cells were cultured in R10 medium and fixed with 3.7% formaldehyde. After fixing, they were stained with anti-GCK, anti-Na,K-ATPase and 1 ng/ml tetramethyl rhodamine B isothiocyanate-conjugated phalloidin (Sigma-Aldrich Cat# P1951) for 30 min at 37 C and respectively. This was followed by secondary antibodies Alexa FluorÒ 555 goat anti-mouse Ig (Biolegend Cat# 405324) and FITC Donkey anti-rabbit IgG (minimal x-reactivity) Antibody (Biolegend 406403). Coverslips were extensively washed, air-dried, and mounted in Vectorshield mounting medium for fluorescence with DAPI (Vector Laboratories Cat# z0603) on glass slides.
Confocal microscopy
Cells were allowed to adhere onto poly-L-lysine coated coverslips and fixed in 4% paraformaldehyde (Thermo Fisher Scientific, Cat# 28906) for 5-10 minutes at room temperature. Where mentioned, permeabilization was carried out using 0.2% Triton X-100 (Sigma-Aldrich, Cat# X100-500ML) in PBS for 5 minutes. Cells were then washed in PBS, blocked in blocking buffer (PBS containing 0.1% Fish skin gelatin; Sigma-Aldrich, Cat# G7765) and 1% serum of the species giving rise to secondary antibodies) for 3-6 hours and then stained with appropriate primary antibodies at 4 C for 16 hours in the dark. Following staining, cells were washed again and stained with corresponding secondary antibodies and DAPI for 30 minutes at room temperature. After multiple PBS washes coverslips were mounted onto slides using ProLong Gold Antifade (Invitrogen/Life Technologies, Cat# P36930) and then examined using a Leica SP5 confocal microscope equipped with a 63 3 1.4 NA objective. Confocal images and Z stacks were acquired and analyzed by Leica LAS software. Repositioning of scale bars and image layouts were prepared using Adobe Photoshop (Adobe Systems). All images in a group were treated equally.
In vitro 6-NBDG uptake assay Freshly isolated or cultured T cells were washed in PBS and resuspended in glucose free T cell medium (GIBCO, Cat# 11879-020) containing various mentioned signaling antibodies and incubated for 45 minutes at 37 C with 5% CO2. A final concentration of 400 mM 6-NBDG (Life Technologies, Cat# N23106) in glucose free T cell medium was then added to the cells and the cells were further incubated for an additional 10-15 minutes. Finally, the cells were washed twice with warm PBS and resuspended in flow cytometry buffer and placed on ice. Immediate analysis was performed using flow cytometry to observe fluorescence uptake by the T cells.
In vitro 6-NBDG uptake assay (human studies) Freshly isolated CD3 + T cells were washed in PBS and cultured 10 6 /mL in R2 (RPMI 1640 supplemented with 2% fetal bovine serum) with recombinant CCL19 and CCL21 (200 ng/mL -Peprotech Cat#300-29B and 300-35) at 37 C with 5% CO 2 . A final concentration of 400 mM 6-NBDG (Life Technologies, Cat# N23106) was added to the cells and incubated for 0, 15, 30 and 60 minutes. Finally, the cells were washed twice with warm PBS, stained for CD4 + T cells and Treg and placed on ice. Immediate analysis was performed using flow cytometry to observe fluorescence uptake by Treg cells.
In vivo 6-NBDG uptake assay To measure glucose uptake activity of T cells in vivo, PKH26 labeled T cells (3x10 6 ) were injected i.p. into mice. A second i.p. injection of 6NBDG (400 mM in Sterile water) was given to the mice immediately afterward. After a 1-hour period, the mice were sacrificed and the mesenteric (draining) lymph nodes and spleen collected for analysis by flow cytometry. Widefield microscopy of the peritoneal membranes was performed to observe influx of labeled T cells into the peritoneal membrane. PKH26 + T cells infiltrating the membranes were further analyzed for 6NBDG uptake (green fluorescence) using image analysis software ImageJ. The number of labeled cells in 10x magnification field views images was counted manually to determine differences in T cell infiltration.
Measurement of ECAR and OCR
Real time bioenergetics analysis of extracellular acidification rates (ECAR) and oxygen consumption rates (OCR) of T cells subjected to antibody stimulation was performed using the XF analyzer (Seahorse biosciences). T cells were cultured in serum free, unbuffered XF assay medium (Seahorse biosciences, Cat# 102365-100) for 1 hour. The cells were then seeded (6x10 5 /well) into the seahorse XF24 cell plates for analysis. Perturbation profiling of the use of metabolic pathways by T cells was achieved by the addition of oligomycin (1 mM), FCCP (1 mM), Antimycin A (1 mM), rotenone (1 mM), D-glucose (10mM), 2-Deoxy-D-glucose (2DG, 50mM; all from Seahorse biosciences, Cat# 103020-100 and 103015-100). Experiments with the Seahorse system were done with the following assay conditions: 2 min mixture; 2 minutes wait; and 4-5 min measurement. Metabolic parameters were calculated. Experiments were done in at least triplicate wells.
Surface staining
For surface staining, cells were resuspended (10 7 /ml) and stained with flurochrome-conjugated antibodies in 100 mL of Flow cytometry buffer made of PBS containing 0.1% sodium azide (Sigma-Aldrich, Cat# S2002-25G) and 1% FBS at 4 C for 30 minutes. CCR7 antibody staining was performed at 37 C for 30 mins. Optimal antibody concentrations for staining were calculated based on manufacturer instructions. Following staining, cells were washed and resuspended with flow cytometry buffer and analyzed immediately. Alternatively, for delayed analysis, cells were fixed in fixation buffer (flow cytometry buffer containing 1% Formaldehyde, Sigma-Aldrich, Cat# 15,812-7)) for 30 minutes at 4 C, washed and stored in flow cytometry buffer at 4 C. The table below indicates the fluorescent antibodies that were used in this study.
Intracellular staining
For intracellular Foxp3 staining, eBioscience Anti-Mouse/Rat Foxp3 Staining Set APC (clone FJK-16S, Thermo Fisher Scientific Cat# 17-5773-82) kit was used. Cells were resuspended (10 7 /ml) and stained with surface antigens as mentioned above and then fixed/permeabilized for 30 minutes at 4 C using Fixation/Permeabilization working solution made from mixing 1 part of the fixation/permebilization concentrate (eBioscience, Cat# 00-5123) to 3 parts of the fixation/permebilization diluent (eBioscience, Cat# 00-5223). The cells were then washed twice in 1X permeabilization buffer (eBioscience, Cat# 00-8333) and stained with fluorochrome conjugated-Foxp3 antibody in 1x permeabilization buffer for 30 minutes at 4 C. A final wash with 1x permeabilization buffer was performed and the cells were then centrifuged and resuspended in 200ul of flow cytometry buffer. For T cell proliferation studies, Treg cells were stimulated with immature BALB/c DCs. 3 hours later, Treg cells were fixed and permeabilized with ice cold 70% ethanol before staining for proliferating cell nuclear antigen (PCNA, clone PC10, BioLegend Cat# 307908).
In vitro AKT phosphorylation (human studies) Freshly isolated concentional CD4 + CD25 -T cells (Tconv) and CD4 + CD25 + (Treg) T cells were washed in PBS and cultured 5 3 10 6 /mL in R2 (RPMI 1640 supplemented with 2% fetal bovine serum). 0.5 3 10 6 CD4 + CD25 -(Tconv) and CD4 + CD25 + (Treg) were plated in 96-well plate and stimulated for 15 minutes or not with chemokines CCL19 and CCL21 (1 mg/mL -Peprotech Cat# 300-29B and 300-35) at 37 C with 5% CO 2 . Cells were immediately fixed to stop stimulation with 2% formaldehyde for 10 minutes at RT in the dark. Cells were washed and resuspended in 100% ice-cold methanol and incubated for 30 minutes on ice. Subsequently, cells were washed twice with PBS 2%FBS and stained for pAKT-s473 (eBioscience, Cat# 17-9715-41) for 30 minutes at 4 C in the dark. Cells were washed, resuspended in PBS 2%FBS and immediately analyzed by flow cytometry.
Western Blotting and coimmunoprecipitation
Whole-cell lysates were lysed in Nonidet P-40 lysis buffer [50 mM HEPES (pH 8.0), 350 mM NaCl, 1% Nonidet P-40, 1 mM EDTA, 1 mM Na3VO4, 1 mM NaF, 20 mM glycerol-2-phosphate, 1 mM PMSF, 1 mM DTT, 10 mg/mL aprotinin, 10 mg/mL leupeptin, and protease inhibitor cocktail (Roche Cat# 11836145001). Equivalent amounts of protein as determined by standard Bradford assay (Bio-Rad Cat# 5000001) were separated by SDS/PAGE and transferred to nitrocellulose membrane (GE Healthcare Life Sciences Cat# 10600002). Membranes were blocked for 2 h at room temperature in 5% milk/TBS-Tween 20 (Sigma Cat# P1379) and were incubated overnight at 4 C with the primary antibodies listed below. HRP-conjugated secondary antibody (1:5000; Amersham Bioscience Cat# NA934) was subsequently added. Films were then developed. The intensity of the bands was quantified using ImageJ (NIH). For coimmunoprecipitation experiments, cell extracts were prepared in RIPA buffer. 250 mg of total protein extract was first precleared with Protein G-Agarose beads (Sigma Cat# P3296) for 1 hour at 4 C, incubated with 5 mg of anti-GCK Ab (Santa Cruz Biotechnology Cat# SC7908) overnight at 4 C and then with Protein G beads for another 16hrs at 4 C. The final pellet was resuspended in 10 mM Tris HCl, pH 7.4, supplemented with 1 mM PMSF and analyzed by western blot for B actin (Santa Cruz Cat# SC161).
Quantitative real time PCR (qRT-PCR)
Tissues were harvested and stored in RNA-later (QIAGEN Cat# 76104) at -80 C until processing. RNA was purified using Trizol reagent (Life Technologies Cat# 15596) according to the manufacturer's instructions and assessed for quality and quantity using absorption measurements. Reverse transcription was performed according to the manufacturer's instruction (Applied Biosystems Cat# 4374966). Gene expression analysis was done using SYBR Green Supermix (Biorad Cat# 1725120) in CFX connect light cycler (Biorad Cat# 1855200). Expression was calculated using the DDCt method (Livak and Schmittgen, 2001 ) and normalized to a housekeeping gene (GAPDH). Primers for qPCR were designed with the help of online tools (Primer 3Plus) using at least one exon junctionbinding site per primer pair. The thermal cycling profile for amplification was 95 C for 10 min, followed by 40 cycles of 95 C for 15 s and 54 C for 1 min. Amplification was at 95 C for 10 min, followed by 40 cycles of 95 C for 15 s and 60 C for 1 min. To ensure the amplification specificity, the melting curve program was set as follows: 95 C for 15 s, 60 C for 1 min, and 95 C for 15 s, right after the PCR cycles. Experiments were done in triplicates.
Lentivirus Preparation for Gene Silencing HEK293T cells were grown in 10cm cell-culture dishes to 70% confluence and were transfected with the above plasmids using the calcium phosphate method. The supernatant was harvested 48 and 72 h after transfection and was concentrated 100-fold in an ultracentrifuge. Aliquots were stored at À80 C. For transduction of Treg cells, cells were seeded in six-well plates and cultured in DMEM to 60%-70% confluence. Lentivirus was added to the cells in the presence of 5 mg/mL Polybrene (Sigma-Aldrich Cat# 107689), and the six-well plate was centrifuged at 2,300 rpm for 90 min at room temperature, followed by 8 h incubation at 37 C with 5% CO 2 . Virus was removed 24 h later; T cells were washed twice with PBS and incubated for 24 h in complete DMEM (Life technologies, Cat# 1852730).
Study population
The Progressione della Lesione Intimale Carotidea (PLIC) Study (a sub-study of the CHECK study) is a large survey of the general population of the northern area of Milan (n = 2.606) (Baragetti et al., 2015; Lorenz et al., 2012; Norata et al., 2009; Norata et al., 2006) Genomic DNA was extracted using Flexigene DNA kit (QIAGEN, Milan, Italy) . Genotyping for the p.Leu446Pro GCKR missense mutation was available on the entire population, using TaqMan allelic discrimination test. The experimental analysis was conducted on a subgroup of 16 subjects, eight Leu 446-GCKR and eight Pro 446-GCKR matched for age and gender.
Blood surface and intracellular staining (human studies) For surface staining, 100mL of whole blood were stained with flurochrome-conjugated antibodies in 50 mL of MACS buffer made of PBS containing, 2% FBS and 2mM EDTA at RT (room temperature) for 30 minutes in the dark. Optimal antibody concentrations for staining were calculated based on manufacturer instructions. Following staining, red blood cells were lysed with 2 mL of 1-step fix/ lyse solution (eBioscience, Cat#00-5333-54) for 20 minutes at RT, washed and resuspended with MACS buffer and analyzed immediately.
Alternatively, for intracellular staining, peripheral blood mononuclear cell (PBMCs) were isolated (as described below) and used for the staining (1-step fix/lyse solution is incompatible with some intracellular stainings). Cells were resuspended (10 7 /mL) and stained in in 50 mL of MACS buffer with surface antigens. For intracellular Foxp3 and Ki67 staining, eBioscience Anti-Mouse/Rat Foxp3 Staining Kit was used (Cat#77-5775-40). Cells were fixed/permeabilized ON at 4 C using Fixation/Permeabilization working solution made from mixing 1 part of the fixation/permebilization concentrate to 3 parts of the fixation/permebilization diluent. Cells were then washed twice in 1X permeabilization buffer and stained with fluorochrome conjugated-Foxp3 and -Ki67 antibodies in 1x permeabilization buffer for 30 minutes at 4 C. A final wash with 1x permeabilization buffer was performed and the cells were then centrifuged and resuspended in 200 mL of MACS buffer. The table above indicates the fluorescent antibodies that were used in this study.
PBMC isolation and CD4
+ CD25
+ Treg cell purification (human studies) For each subject, 30 mL of blood (supplemented with EDTA) were split in two falcon of 15 mL and spin for 12 minutes at 1000xg. Plasma was discarded and the interface between plasma and red blood cells, enriched in leukocytes and platelets (buffy coat), was carefully collected, diluted with cold PBS and stratified on 3 mL of Ficoll-Plaque TM PREMIUM (GE-Healthcare, Cat#17-5442-03). After centrifugation of 35 minutes at 250xg, PBMC layer was carefully collected and was 3 times with 10 mL of cold PBS at 180xg for 12 minutes to get rid of platelets. PBMC were counted and use for CD4 were counted with a hemocytometer and used for migration and suppression assay.
Treg and Tconv cell migration assay (human studies) 300 mL of Treg and Tconv cells (1x10 5 ) of each subject were resuspended in migration medium (RPMI 1640 supplemented with 2% fetal bovine serum) and cultured on Transwell inserts (diameter, 6.5 mm) with 5-mm pore size (Costar, Cat# CLS3421-48EA) polycarbonate membranes. Cells were left to migrate versus migration medium or chemokines CCL19 and CCL21 (200 ng/mL -Peprotech Cat#300-29B and 300-35), placed in the bottom of the well, for 1, 2, 4 and 12 hours. The number of migrated cells was determined by a hemocytometer and data expressed as percentage of migration compared to cultured cells.
Suppression assay (human studies) CD4 + CD25 -Tconv cells were resuspended in MACS buffer (10 7 /mL) and labeled with succinimidyl ester dyes CFSE (2mM -Invitrogen, Cat# C1157) for 10 minutes at RT in the dark. Cells were washed 3 times with MACS buffer and centrifuged at 360xg for 5 minutes. 96 well-plate U-bottom were coated with anti-human CD3 purified antibody (5 mg/mL -eBioscience, Cat#14-0039-82) for 1 hour at 37 C. Tconv were resuspended (10 6 /mL) in complete medium (RPMI 1640 supplemented with 10% FBS, 1mM Na-Pyruvate, 10mM HEPES, 50 mM b-MeOH and pen/strep/glutamine) plus 50 U/mL of IL-2 (Peprotech; Cat#200-02) and 2 mg/mL of anti-human CD28 purified antibody (eBioscience, Cat#14-0289-82) and (1x10 5 /100 mL) were plated. CD4 + CD25 + Treg cells were washed and resuspended in complete medium and added to Tconv cells according to the following proportions (Tconv:Treg): 1:1, 1:0,5, 1:0,25 and 1:0 by performing serial dilution of Treg cells with complete medium in a 96-well plate. The plate was then spun 1 minute at 120 g and incubated at 37 C for 4 days. Cells were then collected and for each subject the percentage of proliferated cells in the presence of Treg cells was compared to the condition of Tconv:Treg cells 1:0 (100% proliferation).
QUANTIFICATION AND STATISTICAL ANALYSIS
The qPCR data were analyzed using the delta delta CT method by taking the CT values of the genes of interest from the house keeping gene following by normalization to the wild-type control sample. Results were done transported to prism before graphic presentation and statistical analysis.
Results are given as the mean per group ± SD. The data were analyzed using a two-tailed unpaired Student's t test and MannWhitney test. A p value of less than 0.05 was considered significant. Experimental datasets from the seahorse were analyzed using one-way ANOVA with Bonferroni correction or Kruskal-Wallis with Dunn's post-test to take into account of multiple comparisons. Where indicated 'n' represent the number of biological replicates. Human data were analyzed by ANCOVA (Analysis of Co-Variances) models between TT and CC genotypes of the rs1260326 GCKR polymorphisms (adjusting by age and gender). In supplemental table variables are presented as mean (standard deviations, SD) if normally distributed or as median (Inter-Quartile Range, IQR) if non normally distributed (Shapiro-Wilk test). t test to compare normally distributed variables and U-Mann Whitney for non-normally distributed variables were performed (p values for each variables are reported; p less than 0.05 are significant). Grubb's test for outliers detection was performed for each variables.
For human results, data are reported as the mean per group ± SEM. The data were analyzed using a two-tailed unpaired Student's t test and Mann-Whitney test. A p value of less than 0.05 was considered significant.
